This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Bezjak A, Tu D, Seymour L, Clark G, Trajkovic A, Zukin M, Ayoub J, Lago S, De Albuquerque Ribeiro R, Gerogianni A, Cyjon A, Noble J, Laberge F, Chan RT-T, Fenton D, von Pawel J, Reck M, Shepherd FA.Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group study BR.21. Journal of Clinical Oncology 24: 3831-3837, No. 24, 20 Aug 2006
Rights and permissions
About this article
Cite this article
Erlotinib improves QOL in NSCLC. Pharmacoecon. Outcomes News 512, 9 (2006). https://doi.org/10.2165/00151234-200605120-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605120-00020